Hangzhou, China · Founded 2020 · Privately Held (backing)
Developer of new drugs designed for autoimmune diseases. E-nitiateBio is based in Hangzhou, China and was founded in 2020. It has raised $42.6 million.
Last price · $/share
—
Implied valuation
—
Total raised
$42.6M
Last round
—
Team — not yet on record
No current team members for E-nitiateBio are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of E-nitiateBio with a free account
·The complete investor list: 11 names
·Watch E-nitiateBio: the Monday email on marks, rounds and moves
